Canada Seeks To Disclose Drug Applicants Under Transparency Drive
Executive Summary
Health Canada is seeking feedback on five transparency proposals that include publishing the names of sponsors whose prescription drugs containing new active substances are under review, and making information on generic drug submissions public for the first time.